Sumitomo Pharma America, Inc.’s Post

Our SMPA colleagues Blair McNeill, Jason Wasikowski and Andrew Hetherington recently cut the ribbon celebrating the expansion of our cell processing center in Morrisville, NC. The site supports production for our commercial treatment for Congenital Athymia and clinical cell therapy programs in Parkinson’s Disease and Retinitis Pigmentosa.

  • No alternative text description for this image
Beth Anne Lang

Situational Leader, Developer of People, Global Regulatory Strategist and Business Partner

3w

Congrats! 🎉 Blair McNeill Karin Pihel great news!!!

Lara Schall

VP, Sales at PDQ Communications

3w

Congrats! 🎉

Like
Reply
Nicole Crane

Trusted Commercial Leader in Diagnostics & Therapeutics | Force Multiplier across Strategy, Analytics & Operations | CRM / BI / Data Owner | Driving Launch Excellence & Growth in Life Sciences

2w

Congrats! 🎉

Like
Reply
Jennifer CL Woo, DVM PhD

Executive Director, Nonclinical & Translational | Global Product Development | Vaccines | Biomarker Strategy | Pharmacology | Cell & Gene Therapy | Immunology | Pathology | Animal Models | Toxicology |

3w

Congrats! 🎉 and well done!

Rich Graves

Executive Multi-Specialty Portfolio Specialist at Sumitomo Pharma America

3w

Congrats! 🎉

Like
Reply
Dave Blackwell

Multi - Specialty Portfolio Specialist at Sunovion Pharmaceuticals

3w

Congrats! 🎉

Like
Reply
Vanessa Fomby

Therauptic Specialist at Sunovion Pharmaceuticals Inc.

2w

Well done!

Like
Reply
Fabien VIAL

Global Executive Finance Leader

3w

Congrats! 🎉

Like
Reply
Christopher McLamb

Senior Executive Assistant to Chief Executive Officer

3w

Magnificent news! Congrats, Blair McNeill Andrew Hetherington and all!

Like
Reply
Brittany Robertson

Vice President, Human Resources | AutoCruitment | Accelerating clinical research by unlocking patient access to life-changing treatments

2w

Amazing news!! Congrats on continuing to build this out and expediting treatment for those in need Blair McNeill Andrew Hetherington

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories